Table of Content

Executive Summary
1 Market Overview
1.1 Introduction to In-Vitro Fertilization (IVF) and its Benefits
1.2 Evolution of IVF
1.3 Steps Involved in IVF
1.4 Additional IVF Procedures
1.5 Key Trends of IVF in the Asia-Pacific Market
1.6 Assumptions and Limitations

2 Market Dynamics
2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.3.1 Growth in Median Age of First-Time Motherhood and Declining Fertility Rates
2.3.2 High Success Rate of IVF Treatment
2.3.3 Increasing Demand for Infertility Treatment to Support Aging Population
2.3.4 Impact of Fertility Tourism
2.4 Market Challenges
2.4.1 Unaffordable Cost of Assisted Reproductive Techniques (ART) in Low- and Middle- Income Countries
2.4.2 Lack of Guidelines and Regulations, and Low Awareness of IVF Treatment in some Under-Developed and Developing Nations
2.4.3 Embryo Smuggling Cases Affecting IVF Services Market
2.5 Market Opportunities
2.5.1 Technological Advancements of Time-Lapse Technology
2.5.2 Advances in Embryo Biopsy and Genetic Screening

3 Competitive Landscape
3.1 Key Developments and Strategies
3.1.1 Agreements, Collaborations and Partnerships
3.1.2 Mergers and Acquisitions
3.1.3 Launches
3.1.4 Rewards and Recognitions
3.1.5 Business Expansions, Regulatory Approvals, and Others
3.2 Market Share Analysis

4 Regulatory Framework
4.1 Overview
4.2 Legal Requirements and Framework at International Level
4.2.1 International Federation of Gynecology and Obstetrics (FIGO)
4.2.2 International Federation of Fertility Societies (IFFS)
4.3 Legal Requirements and Framework at Regional Level (Asia-Pacific)
4.3.1 Asia Pacific Initiative on Reproduction (ASPIRE)
4.4 Legal Requirements and Framework at Country Level (of Asia-Pacific Region)
4.4.1 Fertility Society of Australia (FSA)
4.4.2 Victorian Assisted Reproductive Treatment Authority (VARTA)
4.4.3 Indian Council of Medical Research (ICMR)
4.4.4 The Medical Council of India
4.4.5 Fertility Preservation Society of India
4.4.6 China’s Ministry of Health (CMOH)
4.4.7 Japan Society of Obstetrics and Gynecology (JSOG)
4.4.8 Ministry of Health (MOH), Singapore
4.4.9 Ministry of Health (MOH), Malaysia
4.4.10 Medical Council of Thailand

5 Asia-Pacific IVF Market (by Product Type)
5.1 Overview
5.2 Devices
5.2.1 Gamete Collection and Sorting Systems
5.2.2 Sample Handling Systems
5.2.3 Storage and Maintenance Systems
5.2.4 Consumables
5.2.5 Other IVF Equipment
5.3 Reagents
5.3.1 Embryo Culture Reagents
5.3.2 Cryopreservation Reagents
5.3.3 Gamete Processing Reagents
5.3.4 Others
5.4 Pharmaceuticals
5.5 Services

6 Asia-Pacific IVF Market (by End Users)
6.1 Overview
6.2 Fertility Clinics
6.3 Hospitals
6.4 Clinical Research Centers
6.5 Cryobanks

7 Asia-Pacific IVF Market (by Procedure)
7.1 Overview
7.2 Fresh Donor
7.3 Fresh Nondonor
7.4 Frozen Donor
7.5 Frozen Nondonor

8 Asia-Pacific IVF Market (by Country)
8.1 Overview
8.2 India
8.2.1 India IVF Market, by Product
8.3 Japan
8.3.1 Japan IVF Market, by Product
8.4 China
8.4.1 China IVF Market, by Product
8.5 Australia and New Zealand
8.5.1 Australia and New Zealand IVF Market, by Product
8.6 Singapore
8.6.1 Singapore IVF Market, by Product
8.7 South Korea
8.7.1 South Korea IVF Market, by Product
8.8 Rest-of-Asia Pacific
8.8.1 Rest-of-Asia-Pacific IVF Market, by Product

9 Company Profiles
9.1 Overview
9.2 Adorefem Gynec Pro-Infertility Division
9.2.1 Company Overview
9.2.2 Role of Adorefem Gynec Pro-Infertility Division in the Asia-Pacific IVF Market
9.2.3 SWOT Analysis
9.3 Cook Medical
9.3.1 Company Overview
9.3.2 Role of Cook Medical in the Asia-Pacific IVF Market
9.3.3 SWOT Analysis
9.4 Esco Group of Companies
9.4.1 Company Overview
9.4.2 Role of Esco Group of Companies in the Asia-Pacific IVF Market
9.4.3 SWOT Analysis
9.5 Ferring Pharmaceuticals
9.5.1 Company Overview
9.5.2 Role of Ferring Pharmaceuticals in the Asia-Pacific IVF Market
9.5.3 SWOT Analysis
9.6 FUJIFILM Irvine Scientific
9.6.1 Company Overview
9.6.2 Role of FUJIFILM Irvine Scientific in the Asia-Pacific IVF Market
9.6.3 SWOT Analysis
9.7 Hunter Scientific Limited
9.7.1 Company Overview
9.7.2 Role of Hunter Scientific Limited in the Asia-Pacific IVF Market
9.7.3 SWOT Analysis
9.8 IVFtech ApS
9.8.1 Company Overview
9.8.2 Role of IVFtech ApS in the Asia-Pacific IVF Market
9.8.3 SWOT Analysis
9.9 Labotect Labor-Technik-G?ttingen GmbH
9.9.1 Company Overview
9.9.2 Role of Labotect Labor-Technik-G?ttingen GmbH in the Asia-Pacific IVF Market
9.9.3 SWOT Analysis
9.10 Merck KGaA
9.10.1 Company Overview
9.10.2 Role of Merck KGaA in the Asia-Pacific IVF Market
9.10.3 Financials
9.10.3.1 Key Insights About Financial Health of the Company
9.10.4 SWOT Analysis
9.11 Olympus Corporation
9.11.1 Company Overview
9.11.2 Role of Olympus Corporation in the Asia-Pacific IVF Market
9.11.3 Financials
9.11.3.1 Key Insights About Financial Health of the Company
9.11.4 SWOT Analysis
9.12 Thermo Fisher Scientific Inc.
9.12.1 Company Overview
9.12.2 Financials
9.12.3 Key Insights About Financial Health of the Company
9.12.4 SWOT Analysis
9.13 The Cooper Companies Inc.
9.13.1 Company Overview
9.13.2 Role of The Cooper Companies Inc. in the Asia-Pacific IVF Market
9.13.3 Financials
9.13.3.1 Key Insights About Financial Health of the Company
9.13.4 SWOT Analysis
9.14 Vitrolife AB
9.14.1 Company Overview
9.14.2 Role of Vitrolife AB in the Asia-Pacific IVF Market
9.14.3 Financials
9.14.3.1 Key Insights About Financial Health of the Company
9.14.4 SWOT Analysis
9.15 Snapshot: Bangkok IVF Center
9.15.1 Company Overview
9.15.2 Role of Bangkok IVF Center in the Asia-Pacific IVF Market
9.16 Fertility First
9.16.1 Company Overview
9.16.2 Role of Fertility First in the Asia-Pacific IVF Market

10 Research Scope and Methodology
10.1 What is In-vitro fertilization (IVF)?
10.2 Scope of the Research Study
10.3 Asia-Pacific In-Vitro Fertilization (IVF) Market: Research Methodology



List of Tables



Table 2.1: Impact Analysis of Market Drivers
Table 2.2: Impact Analysis of Market Challenges
Table 2.3: IVF Cost Trend in Different Countries of Asia-Pacific
Table 3.1: Example of Organic and Inorganic Growth Strategies Adopted by Key Companies
Table 4.1: Regulatory Authorities in Countries of Asia-Pacific
Table 5.1: Examples of Device Types Offered by Key Companies
Table 5.2: Examples of Ovum Aspiration Pump Products Developed by Key Companies
Table 5.3: Examples of Imaging System Products Developed by Key Companies
Table 5.4: Examples of Micromanipulator Products Developed by Key Companies
Table 5.5: Examples of Laser System Products Developed by Key Companies
Table 5.6: Examples of Workstation and Cabinet Products Developed by Key Companies
Table 5.7: Examples of Incubator Products Developed by Key Companies
Table 5.8: Examples of Cryosystem Products Developed by Key Companies
Table 5.9: Examples of Consumables Developed by Key Companies
Table 5.10: Examples of Analyzer and Regulator Products Developed by Key Companies
Table 5.11: Examples of Table Products Developed by Key Companies
Table 5.12: Examples of Witness System Products Developed by Key Companies
Table 5.13: Examples of Devices (under Others Category) Developed by Key Companies
Table 5.14: Examples of Reagent Types Offered by Key Companies
Table 5.15: Examples of Imaging System Products Developed by Key Companies
Table 5.16: Examples of Cryopreservation Reagents Developed by Key Companies
Table 5.17: Examples of Gamete Processing Reagents Developed by Key Companies
Table 5.18: Examples of Reagents (under Others category) Developed by Key Companies

List of Figures



Figure 1: Asia-Pacific IVF Market Segmentation, 2018
Figure 2: Asia-Pacific IVF Market Segmentation, 2029
Figure 3: Impact of Market Dynamics, 2018
Figure 4: Share of Key Developments and Strategies, January 2015 to March 2019
Figure 5: Asia-Pacific IVF Devices, Reagents, and Pharmaceuticals Market Share, by Company, 2017
Figure 6: Asia-Pacific IVF Market Share (by Product Type), 2018-2029
Figure 7: Asia-Pacific IVF Market Share (by End User Type), 2018-2029
Figure 8: Asia-Pacific IVF Market Share (by Procedure Type), 2018-2029
Figure 9: Asia-Pacific IVF Market Share (by Country), 2018-2029
Figure 1.1: Major Milestone in the Field of In-Vitro Fertilization
Figure 1.2: Process of IVF
Figure 1.3: Asia-Pacific In-Vitro Fertilization (IVF) Market, 2018-2029
Figure 2.1: Market Dynamics
Figure 2.2: Trends of Fertility Rate in Major Countries of Asia-Pacific (1991-2016)
Figure 3.1: Competitive Landscape (January 2015-March 2019)
Figure 3.2: Share of Key Developments and Strategies, January 2015-March 2019
Figure 3.3: Agreements, Collaborations, and Partnerships (by Companies), January 2015-March 2019
Figure 3.4: Mergers and Acquisitions (by Companies), January 2015-March 2019
Figure 3.5: Launches (by Companies), January 2015-March 2019
Figure 3.6: Rewards and Recognition (by Companies), January 2015-March 2019
Figure 3.7: Asia-Pacific IVF Devices, Reagents, and Pharmaceuticals Market Share, by Companies, 2017 and 2018
Figure 5.1: Different Types of Offerings by Key Players of Asia-Pacific IVF Market
Figure 5.2: Asia-Pacific IVF Market (by Product Type), 2018 and 2029
Figure 5.3: Asia-Pacific IVF Devices Market, 2019-2029
Figure 5.4: Asia-Pacific IVF Devices Market (by Device Type), 2018 and 2029
Figure 5.5: Asia-Pacific Gamete Collection and Sorting Systems Market, 2019-2029
Figure 5.6: Asia-Pacific IVF Sample Handling Systems Market, 2019-2029
Figure 5.7: Asia-Pacific IVF Storage and Maintenance Systems Market, 2019-2029
Figure 5.8: Asia-Pacific IVF Consumables Market, 2019-2029
Figure 5.9: Asia-Pacific Other IVF Equipment Market, 2019-2029
Figure 5.10: Asia-Pacific IVF Reagents Market, 2019-2029
Figure 5.11: Asia-Pacific IVF Reagents Market (by Reagents Type), 2018 and 2029
Figure 5.12: Asia-Pacific IVF Embryo Culture Reagents Market, 2018-2029
Figure 5.13: Asia-Pacific IVF Cryopreservation Reagents Market, 2018-2029
Figure 5.14: Asia-Pacific IVF Gamete Processing Reagents Market, 2019-2029
Figure 5.15: Asia-Pacific IVF Reagents Market (by Other Reagents), 2018-2029
Figure 5.16: Asia-Pacific IVF Pharmaceuticals Market, 2018-2029
Figure 5.17: Historical Trend of Number of IVF Cycles in Countries of Asia-Pacific
Figure 5.18: Asia-Pacific IVF Pharmaceuticals Market, 2018-2029
Figure 6.1: Segmentation of Asia-Pacific IVF Market, by End Users
Figure 6.2: Asia-Pacific IVF Market (by End Users), 2018 and 2029
Figure 6.3: Asia-Pacific IVF Market for Fertility Clinics, 2018-2029
Figure 6.4: Asia-Pacific IVF Market for Hospitals, 2018-2029
Figure 6.5: Asia-Pacific IVF Market for Clinical Research Centers, 2018-2029
Figure 6.6: Asia-Pacific IVF Market for Cryobanks, 2018-2029
Figure 7.1: Segmentation of Asia-Pacific IVF Market, by Procedure
Figure 7.2: Asia-Pacific IVF Market (by Procedure), 2018 and 2029
Figure 7.3: Asia-Pacific IVF Market by Fresh Donor, 2018-2029
Figure 7.4: Asia-Pacific IVF Market by Fresh Nondonor, 2018-2029
Figure 7.5: Asia-Pacific IVF Market by Fresh Donor, 2018-2029
Figure 7.6: Asia-Pacific IVF Market by Frozen Nondonor, 2018-2029
Figure 8.1: Asia-Pacific IVF Market, 2018-2029
Figure 8.2: Asia-Pacific IVF Market (by Country), 2018 and 2029
Figure 8.3: India IVF Market, 2018-2029
Figure 8.4: India IVF Market, by Product, 2018-2029
Figure 8.5: Japan IVF Market, 2018-2029
Figure 8.6: Japan IVF Market, by Product, 2018-2029
Figure 8.7: China IVF Market, 2018-2029
Figure 8.8: China IVF Market, by Product, 2018-2029
Figure 8.9: Australia and New Zealand IVF Market, 2018-2029
Figure 8.10: Australia and New Zealand IVF Market, by Product, 2018-2029
Figure 8.11: Singapore IVF Market, 2018-2029
Figure 8.12: Singapore IVF Market, by Product, 2018-2029
Figure 8.13: South Korea IVF Market, 2018-2029
Figure 8.14: South Korea IVF Market, by Product, 2018-2029
Figure 8.15: Rest-of-Asia Pacific IVF Market, 2018-2029
Figure 8.16: Rest-of-Asia-Pacific IVF Market, by Product, 2018-2029
Figure 9.1: Shares of Key Company Profiles
Figure 9.2: Adorefem Gynec Pro-Infertility Division: Product Portfolio for Asia-Pacific IVF Market
Figure 9.3: Adorefem Gynec Pro-Infertility Division: SWOT Analysis
Figure 9.4: Cook Medical: Product Portfolio for Asia-Pacific IVF Market
Figure 9.5: Cook Medical: SWOT Analysis
Figure 9.6: Esco Group of Companies: Product Portfolio for Asia-Pacific IVF Market
Figure 9.7: Esco Group of Companies: SWOT Analysis
Figure 9.8: Ferring Pharmaceuticals: Product Portfolio for Asia-Pacific IVF Market
Figure 9.9: Ferring Pharmaceuticals: SWOT Analysis
Figure 9.10: FUJIFILM Irvine Scientific: Product Portfolio for Asia-Pacific IVF Market
Figure 9.11: FUJIFILM Irvine Scientific: SWOT Analysis
Figure 9.12: Hunter Scientific Limited: Product Portfolio for Asia-Pacific IVF Market
Figure 9.13: Hunter Scientific Limited: SWOT Analysis
Figure 9.14: IVFtech ApS: Product Portfolio for Asia-Pacific IVF Market
Figure 9.15: IVFtech ApS: SWOT Analysis
Figure 9.16: Labotect Labor-Technik-G?ttingen GmbH: Product Portfolio for Asia-Pacific IVF Market
Figure 9.17: Labotect Labor-Technik-G?ttingen GmbH: SWOT Analysis
Figure 9.18: Merck KGaA: Product Portfolio for Asia-Pacific IVF Market
Figure 9.19: Merck KGaA: Overall Financials, 2016-2018
Figure 9.20: Merck KGaA: Revenue (by Segment), 2016-2018
Figure 9.21: Merck KGaA: Revenue (by Region), 2016-2018
Figure 9.22: Merck KGaA: R&D Expenditure (2016-2018)
Figure 9.23: Merck KGaA: SWOT Analysis
Figure 9.24: Olympus Corporation: Product Portfolio for Asia-Pacific IVF Market
Figure 9.25: Olympus Corporation: Overall Financials, 2016-2018
Figure 9.26: Olympus Corporation: Revenue (by Segment), 2016-2018
Figure 9.27: Olympus Corporation: Revenue (by Region), 2016-2018
Figure 9.28: The Olympus Corporation: R&D Expenditure (2016-2018)
Figure 9.29: Olympus Corporation: SWOT Analysis
Figure 9.30: Thermo Fisher Scientific Inc.: Product Portfolio for Asia-Pacific IVF Market
Figure 9.31: Thermo Fisher Scientific Inc: Overall Financials, 2016-2018
Figure 9.32: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
Figure 9.33: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 9.34: Thermo Fisher Scientific Inc.: R&D Expenditure (2016-2018)
Figure 9.35: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 9.36: The Cooper Companies Inc.: Product Portfolio for Asia-Pacific IVF Market
Figure 9.37: The Cooper Companies Inc.: Overall Financials, 2016-2018
Figure 9.38: The Cooper Companies Inc.: Revenue (by Segment), 2016-2018
Figure 9.39: The Cooper Companies Inc.: Revenue (by CooperSurgical Category), 2016-2018
Figure 9.40: The Cooper Companies Inc.: Revenue (by Region), 2016-2018
Figure 9.41: The Cooper Companies Inc.: R&D Expenditure (2016-2018)
Figure 9.42: The Cooper Companies Inc.: SWOT Analysis
Figure 9.43: Vitrolife AB: Product Portfolio for Asia-Pacific IVF Market
Figure 9.44: Vitrolife AB: Overall Financials, 2015-2017
Figure 9.45: Vitrolife AB: Revenue (by Segment), 2015-2017
Figure 9.46: Vitrolife AB: Revenue (by Region), 2015-2017
Figure 9.47: Vitrolife AB: R&D Expenditure (2015-2017)
Figure 9.48: Vitrolife AB: SWOT Analysis
Figure 9.49: Bangkok IVF Center: Service Portfolio for Asia-Pacific IVF Market
Figure 9.50: Fertility First: Service Portfolio for Asia-Pacific IVF Market
Figure 10.1: Segmentation of the Asia-Pacific IVF Market
Figure 10.2: Asia-Pacific IVF Market Research Methodology
Figure 10.3: Primary Research
Figure 10.4: Secondary Research
Figure 10.5: Data Triangulation
Figure 10.6: Bottom-up Approach (Segment-wise Analysis)
Figure 10.7: Top-Down Approach (Segment-wise Analysis)
Figure 10.8: Assumptions and Limitations
Figure 10.9: Considered Factors for Data Prediction and Modelling